amifostine anhydrous has been researched along with thromboxane b2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Catravas, GN; Donlon, M; Helgeson, EA; Steel, L; Wolfe, WW | 1 |
Grignani, G; Maiolo, A; Porta, C; Tua, A | 1 |
2 other study(ies) available for amifostine anhydrous and thromboxane b2
Article | Year |
---|---|
WR-2721 inhibition of radiation-induced prostaglandin excretion in rats.
Topics: Amifostine; Animals; Cobalt Radioisotopes; Dinoprost; Gamma Rays; Male; Organothiophosphorus Compounds; Prostaglandins; Prostaglandins E; Prostaglandins F; Radiation Injuries, Experimental; Radiation-Protective Agents; Rats; Rats, Inbred Strains; Thromboxane B2 | 1985 |
Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
Topics: Adenosine Diphosphate; Adult; Amifostine; Antioxidants; Blood Platelets; Collagen; Dose-Response Relationship, Drug; Free Radical Scavengers; Humans; Nitric Oxide; Oxidative Stress; Platelet Activating Factor; Platelet Activation; Platelet Aggregation Inhibitors; Radiation-Protective Agents; Reactive Oxygen Species; Thromboxane B2 | 2000 |